Association between insulin resistance surrogate indices and incident chronic kidney disease among the population with cardiovascular-kidney-metabolic syndrome stage 0-3: a cohort study

The human body is a complex machine where the heart, kidneys, and metabolic system work in a tightly linked team. When this team begins to struggle, it often starts with a condition called insulin resistance. This is not a disease in itself, but a state where the body's cells stop responding properly to insulin, the hormone that helps turn food into energy. As a result, the body has to work harder to manage blood sugar and fat, creating a slow-burning stress that can damage blood vessels and organs over time. Doctors have recently begun grouping these interconnected risks—heart trouble, kidney issues, and metabolic problems—into a single framework called cardiovascular-kidney-metabolic syndrome. The goal of this framework is to catch problems early, before they become serious, by looking at people who show signs of trouble but have not yet suffered a major event like a heart attack or kidney failure. The challenge lies in finding simple, inexpensive ways to spot who is at highest risk for kidney damage among these people, especially since the kidneys can hide their distress until significant damage has already occurred.

A team of researchers in China set out to test whether six different mathematical tools, all derived from routine blood tests and body measurements, could predict who would develop kidney disease over the next four years. They focused on a large group of adults aged 45 and older who were already showing some signs of metabolic or heart risk but had not yet reached the most severe stages of the syndrome. The researchers used data from a national survey that tracks the health of Chinese adults, looking specifically at those whose kidney function was still normal at the start of the study. They calculated six different scores for each person. Three of these scores were based simply on the relationship between blood sugar and triglycerides, a type of fat in the blood. The other three scores added information about body size and fat distribution, such as waist circumference or body mass index, to the basic sugar-and-fat calculation. The team wanted to see which of these tools was best at identifying the people who would go on to develop chronic kidney disease, defined as a drop in kidney function below a specific safety threshold.

The study followed 4,068 participants for four years. At the end of that time, 120 people had developed kidney disease. When the researchers looked back at the starting data, they found that everyone who developed the disease had higher scores on all six tools compared to those who remained healthy. However, the story changed when the researchers adjusted their analysis to account for other known risk factors like high blood pressure, diabetes, and age. In these more rigorous tests, the simple sugar-and-fat scores lost their ability to predict the disease. They no longer stood out as unique warning signs once the other health factors were taken into account. In contrast, the three tools that combined the sugar-and-fat data with measurements of body fat and size remained strong predictors. These composite scores, which blend metabolic data with physical measurements of the waist or body mass, continued to show a clear link to kidney risk even after the researchers controlled for high blood pressure, diabetes, and other variables.

The researchers found that the tools incorporating body measurements were particularly effective. One score that multiplied the sugar-and-fat index by waist circumference, and another that did the same with the waist-to-height ratio, showed the most consistent results. People with the highest scores on these tools were significantly more likely to develop kidney disease than those with the lowest scores. The study also revealed that these tools worked differently depending on the person. For example, the link between the scores and kidney disease was stronger in people who did not drink alcohol and in those with a lower body mass index. Interestingly, the researchers found that these tools were not perfect at predicting who would get sick on their own. While they were good at showing a general trend, they could not definitively separate the healthy from the sick in every individual case. This suggests that while these scores are useful for spotting groups at risk, they are not yet sharp enough to be used as a standalone screening test for every person.

The findings suggest that for middle-aged and older adults who are already at risk for heart or metabolic issues, adding a simple measurement of body fat to a standard blood test provides valuable extra information about kidney health. The study indicates that the simple sugar-and-fat ratio alone is not enough to capture the full picture of kidney risk in this population. Instead, the combination of metabolic data with physical signs of fat distribution offers a more robust warning system. The researchers conclude that these low-cost, easy-to-calculate scores could help doctors identify which patients need closer monitoring of their kidney function. By using these tools alongside existing risk assessments, healthcare providers might be able to catch kidney problems earlier in the people who need it most, potentially preventing the progression to more severe disease. The study does not claim to have solved the problem of kidney disease prediction, but it offers a practical, accessible way to refine risk assessment for a large and growing group of people.